BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 8986808)

  • 21. Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes.
    Cross SL; Halden NF; Lenardo MJ; Leonard WJ
    Science; 1989 Apr; 244(4903):466-9. PubMed ID: 2497520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene.
    Thanos D; Maniatis T
    Cell; 1992 Nov; 71(5):777-89. PubMed ID: 1330326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of IL-2 and IL-4 gene expression by nodularin through the reduced NF-AT binding activity.
    Yea SS; Kim HM; Jeon YJ; Oh HM; Jeong HG; Yang KH
    Toxicol Lett; 2000 Apr; 114(1-3):215-24. PubMed ID: 10713487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B.
    Stein B; Baldwin AS
    Mol Cell Biol; 1993 Nov; 13(11):7191-8. PubMed ID: 8413306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of NF-kappaB and NFAT with the interferon-gamma promoter.
    Sica A; Dorman L; Viggiano V; Cippitelli M; Ghosh P; Rice N; Young HA
    J Biol Chem; 1997 Nov; 272(48):30412-20. PubMed ID: 9374532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression.
    Li-Weber M; Davydov IV; Krafft H; Krammer PH
    J Immunol; 1994 Nov; 153(9):4122-33. PubMed ID: 7930616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An HMG-like protein that can switch a transcriptional activator to a repressor.
    Lehming N; Thanos D; Brickman JM; Ma J; Maniatis T; Ptashne M
    Nature; 1994 Sep; 371(6493):175-9. PubMed ID: 8072548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome.
    Yie J; Merika M; Munshi N; Chen G; Thanos D
    EMBO J; 1999 Jun; 18(11):3074-89. PubMed ID: 10357819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia induces high-mobility-group protein I(Y) and transcription of the cyclooxygenase-2 gene in human vascular endothelium.
    Ji YS; Xu Q; Schmedtje JF
    Circ Res; 1998 Aug; 83(3):295-304. PubMed ID: 9710122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an NF-Y/HMG-I(Y)-binding site in the human IL-10 promoter.
    Lin SC
    Mol Immunol; 2006 Mar; 43(9):1325-31. PubMed ID: 16256199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
    Stütz AM; Woisetschläger M
    J Immunol; 1999 Oct; 163(8):4383-91. PubMed ID: 10510379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interleukin 2 receptor alpha chain/CD25 promoter is a target for nuclear factor of activated T cells.
    Schuh K; Twardzik T; Kneitz B; Heyer J; Schimpl A; Serfling E
    J Exp Med; 1998 Oct; 188(7):1369-73. PubMed ID: 9763616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of constitutive and inducible transcription factors binding to the P2 NF-AT site in the human interleukin-4 promoter.
    Li-Weber M; Salgame P; Hu C; Krammer PH
    Gene; 1997 Apr; 188(2):253-60. PubMed ID: 9133600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element.
    Good L; Maggirwar SB; Sun SC
    EMBO J; 1996 Jul; 15(14):3744-50. PubMed ID: 8670878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor.
    Chung SW; Kang BY; Kim TS
    Mol Pharmacol; 2003 Nov; 64(5):1169-79. PubMed ID: 14573767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6.
    Kunsch C; Lang RK; Rosen CA; Shannon MF
    J Immunol; 1994 Jul; 153(1):153-64. PubMed ID: 8207232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An 11-base-pair DNA sequence motif apparently unique to the human interleukin 4 gene confers responsiveness to T-cell activation signals.
    Abe E; De Waal Malefyt R; Matsuda I; Arai K; Arai N
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2864-8. PubMed ID: 1532661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The non-histone chromosomal protein HMG-I(Y) contributes to repression of the immunoglobulin heavy chain germ-line epsilon RNA promoter.
    Kim J; Reeves R; Rothman P; Boothby M
    Eur J Immunol; 1995 Mar; 25(3):798-808. PubMed ID: 7705411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.
    Briegel K; Hentsch B; Pfeuffer I; Serfling E
    Nucleic Acids Res; 1991 Nov; 19(21):5929-36. PubMed ID: 1945879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
    Mondal D; Alam J; Prakash O
    J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.